XTLB
NASDAQ
IL
XTL Biopharmaceuticals Ltd. - American Depositary Shares
$2.43
▼ $-0.02
(-0.82%)
Vol 12K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Beta
0.75
52W
$2–$12
Price Chart
Similar Stocks
Fundamentals Trend
| Metric | 2019-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | — | — | — | — | — |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | — | — | — | — | — |
| Current Ratio | 45.85 | — | — | — | — | — |
Key Ratios
52W High
$11.80
52W Low
$2.10
$2.10
52-Week Range
$11.80
How does XTLB compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
XTLB valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
—
▼
0%
below
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
XTLB profitability vs Biotechnology peers
ROE
—
▼
0%
below
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
—
▼
0%
below
peers
(-46.7%)
vs Peers
vs Industry
Top tier
XTLB financial health vs Biotechnology peers
D/E ratio
—
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
—
▼
0%
below
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.8
▼
22%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
XTLB fundamentals radar
XTLB
Peer median
Industry
XTLB profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
XTLB vs peers: key metrics
Latest News
No related news yet